Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107


Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.

Al Kaabi A, Traupe T, Stutz M, Buchs N, Heller M.

PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.


Coronary collateral growth by external counterpulsation: a randomised controlled trial.

Gloekler S, Meier P, de Marchi SF, Rutz T, Traupe T, Rimoldi SF, Wustmann K, Steck H, Cook S, Vogel R, Togni M, Seiler C.

Heart. 2010 Feb;96(3):202-7. doi: 10.1136/hrt.2009.184507. Epub 2009 Nov 5.


Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial).

Buschmann EE, Utz W, Pagonas N, Schulz-Menger J, Busjahn A, Monti J, Maerz W, le Noble F, Thierfelder L, Dietz R, Klauss V, Gross M, Buschmann IR; Arteriogenesis Network (Art. Net.).

Eur J Clin Invest. 2009 Oct;39(10):866-75. doi: 10.1111/j.1365-2362.2009.02192.x. Epub 2009 Jul 2.


Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements--design of the arteriogenesis network trial 2.

Pagonas N, Utz W, Schulz-Menger J, Busjahn A, Monti J, Thierfelder L, Dietz R, Klauss V, Gross M, Buschmann IR, Buschmann EE; Arteriogenesis Network (Art.Net.).

Int J Cardiol. 2010 Dec 3;145(3):432-7. doi: 10.1016/j.ijcard.2009.05.050. Epub 2009 Jun 17.


Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N.

Eur Heart J. 2011 Aug;32(16):2034-41. doi: 10.1093/eurheartj/ehq478. Epub 2010 Dec 24.


Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.

Arthritis Res Ther. 2009;11(5):R156. doi: 10.1186/ar2833. Epub 2009 Oct 15.


Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.

Sartori MT, Della Puppa A, Ballin A, Campello E, Radu CM, Saggiorato G, d'Avella D, Scienza R, Cella G, Simioni P.

Thromb Haemost. 2013 Aug;110(2):378-85. doi: 10.1160/TH12-12-0957. Epub 2013 Jun 27.


Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease.

Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, Li S, Zhao J, Chen H.

PLoS One. 2013 Dec 5;8(12):e80738. doi: 10.1371/journal.pone.0080738. eCollection 2013.


Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.

Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwland R, Brooks SA, Ferry B.

Thromb Res. 2011 Apr;127(4):370-7. doi: 10.1016/j.thromres.2010.12.014. Epub 2011 Jan 22.


Evaluation of microparticles in whole blood by multicolour flow cytometry assay.

Christersson C, Johnell M, Siegbahn A.

Scand J Clin Lab Invest. 2013 Apr;73(3):229-39. doi: 10.3109/00365513.2013.769278. Epub 2013 Mar 1.


External counterpulsation augments blood pressure and cerebral flow velocities in ischemic stroke patients with cerebral intracranial large artery occlusive disease.

Lin W, Xiong L, Han J, Leung TW, Soo YO, Chen X, Wong KS.

Stroke. 2012 Nov;43(11):3007-11. doi: 10.1161/STROKEAHA.112.659144. Epub 2012 Sep 20.


Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.

Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH.

Arthritis Rheum. 2011 Oct;63(10):3067-77. doi: 10.1002/art.30499.


Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.

Horio T, Fujita M, Tanaka Y, Ishihara M, Kishimoto S, Nakamura S, Hase K, Maehara T.

J Vasc Surg. 2011 Sep;54(3):791-8. doi: 10.1016/j.jvs.2011.02.060. Epub 2011 May 28.


Effect of external counterpulsation on cardiac work following cardiac surgery: implications of the mechanism responsible for clinical benefits.

Shimizu T, Kyo S, Morizumi S, Ando T, Gon S, Suematsu Y.

J Cardiol. 2012 Jan;59(1):84-90. doi: 10.1016/j.jjcc.2011.08.005. Epub 2011 Oct 22.


Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.

Amabile N, Guérin AP, Tedgui A, Boulanger CM, London GM.

Nephrol Dial Transplant. 2012 May;27(5):1873-80. doi: 10.1093/ndt/gfr573. Epub 2011 Oct 29.


T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis.

Philippova M, Suter Y, Toggweiler S, Schoenenberger AW, Joshi MB, Kyriakakis E, Erne P, Resink TJ.

Eur Heart J. 2011 Mar;32(6):760-71. doi: 10.1093/eurheartj/ehq206. Epub 2010 Jun 28.


Therapeutic arteriogenesis in peripheral arterial disease: combining intervention and passive training.

Bondke Persson A, Buschmann EE, Lindhorst R, Troidl K, Langhoff R, Schulte KL, Buschmann I.

Vasa. 2011 May;40(3):177-87. doi: 10.1024/0301-1526/a000092. Review.


Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.

Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1268-75. doi: 10.1164/rccm.200710-1458OC. Epub 2008 Feb 28.


A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.

Iversen LV, Ostergaard O, Nielsen CT, Jacobsen S, Heegaard NH.

J Immunol Methods. 2013 Feb 28;388(1-2):49-59. doi: 10.1016/j.jim.2012.12.001. Epub 2012 Dec 12.

Items per page

Supplemental Content

Write to the Help Desk